OUR FOCUS: UN POLITICAL DECLARATION TARGET No. 4.

Slides:



Advertisements
Similar presentations
How Universal will Universal Access be in Europe by 2010? Eddy Beck Evaluation Department UNAIDS, Geneva
Advertisements

Research for Universal Health Coverage The World Health Report 2013.
"3 by 5" progress December 2005 Progress on global access to HIV antiretroviral therapy | 12 April |2 | Antiretroviral therapy coverage in low-
Women and ARV-based Prevention: Challenges and Opportunities Tim Mastro, MD, DTM&H AIDS 2014 Melbourne, Australia 24 July 2014.
Are We Reaching the Children? Issues in Pediatric HIV Programming Anouk Amzel, MD, MPH Jacqueline Firth, MD, MPH Office of HIV/AIDS USAID March 7, 2014.
Long-term Projections of the Cost of Treatment Under Various Scenarios – Opportunities for Efficiency and Effectiveness? Arin Dutta, Cathy Barker, and.
Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive DR. Nicholas Muraguri OGW, MD,MPH, MBA,
The HIV Engagement in Care Cascade Edward Gardner, MD Associate Professor of Medicine Denver Public Health University of Colorado Denver.
Brazzaville, Congo 5-7 March 2014
People receiving antiretroviral therapy, 2005 to June 2014, all countries.
The Global Response to AIDS: Does It Pass the Test for Women? Peter Piot Institute for Global Health Imperial College.
Higher antiretroviral treatment coverage is associated with lower HIV infection rates: analysis of 51 low and middle-income countries Andrew Hill, Liverpool.
UNAIDS, Regional Support Team, Eastern and Southern Africa
Moving to the final chapter of the AIDS epidemic.
AIDS 2014 – Ending the adolescent AIDS epidemic Ungdom og hiv Anne May Andersen, Norad.
Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University July 17, 2011 The first step is admitting you have a problem.
HIV/AIDS: A Global and Regional Perspective AIDS in Post 2015 Development Agenda.
Why Healthcare Workers are Key to Ending the AIDS Epidemic Capitol Hill, March 2, 2015 Lisa Carty, Director UNAIDS Liaison Office, Washington, DC 1.
Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.
Antiretroviral Treatment (ART) & Human resources Wim Van Damme Department of Public Health ITM, 17 October 2006.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
Population-based impact of ART in high HIV prevalence settings Marie-Louise Newell Professor of Global Health Faculty of Medicine, Faculty of Social and.
ART for Prevention From Evidence to Action Wafaa El-Sadr, MD, MPH ICAP-Columbia University.
9. Fundamental Concepts of Macroeconomics 1.Objectives and Methods of Macroeconomics 2.Economic Growth 3.National Accounting.
 Globalization.  Canada & south Africa Income per person(GDP per capita inflation adjusted)
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
Edward Mills PhD, Associate Professor, Faculty of Health Sciences University of Ottawa AIDS Mortality Among Men in Africa: An overview of the evidence.
HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4
The State of the Epidemic in 2010 by Professor Alan Whiteside HEARD House of Lords 9 th March 2010 DFID HIV Leaders Meeting.
‘Gaps in the global HIV/AIDS success story Copenhagen December 2 nd 2013 Gaps in the global HIV/AIDS success story Briefing on HIV/AIDS in Europe Martin.
AFRICA HIV/AIDS AIDS DATA SOURCE: UNAIDS 2007 REPORT WORLD HEALTH ORGANIZATION.
ECONOMIC SPILLOVER EFFECTS OF HIV TREATMENT ON RURAL SOUTH AFRICAN HOUSEHOLDS Jacob Bor 1,2, Frank Tanser 1, Marie-Louise Newell 1,3, Till Bärnighausen.
Epidémiologie Problème mondial / problématique en fonction de l’âge et le sexe Mise en place de la prophylaxie.
What will it take to turn the tide? Bernhard Schwartländer Yogan Pillay Till Baernighausen.
High-impact interventions. Number of people living with HIV who were not receiving antiretroviral therapy, 2014 and 2015 Source: UNAIDS estimates, 2014.
Central Asia Regional Health Security Workshop George C. Marshall European Center for Security Studies April 2012, Garmisch-Partenkirchen, Germany.
The investment framework - Critical enablers are not a luxury! Bernhard Schwartlander.
Scaling up access to antiretroviral therapy in low- and middle-income countries: global and regional progress in 2008 Yves Souteyrand HIV/AIDS Department,
Grinsztejn B, et al, Lancet Infect Dis, March 4 th 2014 PRIMARY COMBINED M&M OUTCOME FIRST AIDS DEFINING EVENT FIRST TB EVENT DEATH.
Figure 1: Percentage change in the number of people dying from AIDS-related causes between 2005 and 2011 in countries with 100 or more AIDS-related deaths.
Towards an improved investment approach for an effective response to HIV Dr Bernhard Schwartländer UNAIDS.
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
A Call to Action Children – The missing face of AIDS.
INVESTING IN COMMUNITY SYSTEMS TO SUPPORT LIFELONG ART INITIATED IN MATERNAL & CHILD HEALTH SETTINGS Dr. Chewe Luo MD, PhD, FRCP UNICEF PROGRAM DIVISION.
Number of people living with HIV on antiretroviral therapy, global, 2010–2015
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
Contents - HIV global slides
HIV System Assessment with Longitudinal Treatment Cascade in KwaZulu-Natal, South Africa Noah Haber,1 Frank Tanser,2 Kevindra Naidu,2 Tinofa Mutevedzi,2.
Number of people receiving antiretroviral therapy in
The State of the Epidemic in 2010
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
Overview of Global HIV Epidemic
27 years of responding to AIDS
27 years of responding to AIDS
XVII International AIDS Conference
Charting a new course for HIV and health in Africa:
People who inject drugs
Initiatives in HIV.
"3 by 5" progress December 2005.
CommCare as a Tool to Reduce Loss to Follow Up
Tiffany G. Harris, PhD, MS Director of Strategic Information
Antiretroviral therapy coverage in sub-Saharan Africa,
Estimating trends in life expectancy in HIV-positive individuals
July 21, 2016 Potential Domestic Source Financing for Scaled Up Antiretroviral Therapy in 97 Countries, 2016–2020 Arin Dutta, Catherine Barker, and Ashley.
Volume 2, Issue 4, Pages e159-e168 (April 2015)
Hidden Opportunities - What Will It Take to Reach in Eastern Europe?
2005 Country progress towards 2001 Declaration of Commitment
Contents - HIV global slides
The IAS TB/HIV Research Prizes are awarded to:
Presentation transcript:

OUR FOCUS: UN POLITICAL DECLARATION TARGET No. 4

54% of all people eligible were receiving antiretroviral therapy in low- and middle-income countries in 2011 Percentage receiving ART in Legend Source: UNAIDS, 2012 Number of people eligible for antiretroviral therapy.

Return for investment Sources: Bärnighausen T et al, The economic benefits of ART: evidence from a complete population cohort in rural South Africa 2nd International HIV Workshop on Treatment as Prevention, Vancouver, Canada, April Before treatment After starting treatment Likelihood of employment before and after starting antiretroviral therapy KwaZulu-Natal, South Africa

Percentage of people retained in treatment and care after diagnosis, USA and Mozambique Source: Gardner E M et al. Clin Infect Dis. 2011;52: ; Micek et al JAIDS 2009 Tested <30 days Mozambique USA Diagnosed with HIV Linked/ enrolled in care Eligible for ART Initiated ART Adherent or undetectable Retained in care 100% 0 Retained in treatment and care

Percentage of people retained in treatment and care after diagnosis, USA and Mozambique Source: Gardner E M et al. Clin Infect Dis. 2011;52: ; Micek et al JAIDS 2009 To improve testing:  Reduce stigma in the community and in healthcare settings  Strengthen community support and referral networks  Enhance human rights literacy Tested <30 days Mozambique USA Diagnosed with HIV Linked/ enrolled in care Eligible for ART Initiated ART Adherent or undetectable Retained in care 100% 0 Retained in treatment and care

Percentage of people retained in treatment and care after diagnosis, USA and Mozambique Source: Gardner E M et al. Clin Infect Dis. 2011;52: ; Micek et al JAIDS 2009 Improve enrolment in care:  Expand community-centred delivery  Overcome cost & transport barriers  Enhance treatment & rights literacy Tested <30 days Mozambique USA Diagnosed with HIV Linked/ enrolled in care Eligible for ART Initiated ART Adherent or undetectable Retained in care 100% 0 Retained in treatment and care

Percentage of people retained in treatment and care after diagnosis, USA and Mozambique Source: Gardner E M et al. Clin Infect Dis. 2011;52: ; Micek et al JAIDS 2009 Get more people on treatment:  Enhance peer support programmes  Reduce costs  Overcome transport barriers  Ensure adequate nutrition  Reduce stigma in healthcare settings Tested <30 days Mozambique USA Diagnosed with HIV Linked/ enrolled in care Eligible for ART Initiated ART Adherent or undetectable Retained in care 100% 0 Retained in treatment and care

Percentage of people retained in treatment and care after diagnosis, USA and Mozambique Source: Gardner E M et al. Clin Infect Dis. 2011;52: ; Micek et al JAIDS 2009 Retain people on treatment:  Adherence support programmes  Reduce gender inequalities  Reduce fear of disclosure  Overcome cost and transport barriers  Referral and support programmes for migrants Tested <30 days Mozambique USA Diagnosed with HIV Linked/ enrolled in care Eligible for ART Initiated ART Adherent or undetectable Retained in care 100% 0 Retained in treatment and care